Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life

Jennifer L. Hundley, Christie L. Carroll, Wei Lang, Beverly Snively, Gil Yosipovitch, Steven R. Feldman, Joseph L. Jorizzo

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Background: Dermatomyositis affects visible skin and causes disease symptoms that can affect patients' quality of life (QOL). Methods: In all, 71 patients with dermatomyositis or dermatomyositis sine myositis completed two QOL measures (the Skindex-16 and the Dermatology Life Quality Index) and a visual analog scale for pruritus. Disease severity was assessed by Physician's Global Assessment. Results: The mean Dermatology Life Quality Index score was 10.7 and the mean Skindex-16 score was 51.1. Itching contributed to impact on both the Dermatology Life Quality Index and Skindex-16. Females reported worse QOL. Limitations: The effect of treatment on quality of life was not assessed in these analyses. Conclusion: QOL impairment in dermatomyositis is greater than in other skin conditions including psoriasis and atopic dermatitis. Pruritus is an important treatable factor that significantly impacts QOL for patients with dermatomyositis.

Original languageEnglish (US)
Pages (from-to)217-220
Number of pages4
JournalJournal of the American Academy of Dermatology
Volume54
Issue number2
DOIs
StatePublished - Feb 1 2006
Externally publishedYes

Fingerprint

Dermatomyositis
Quality of Life
Skin
Pruritus
Dermatology
Myositis
Atopic Dermatitis
Visual Analog Scale
Psoriasis
Skin Diseases
Physicians

ASJC Scopus subject areas

  • Dermatology

Cite this

Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. / Hundley, Jennifer L.; Carroll, Christie L.; Lang, Wei; Snively, Beverly; Yosipovitch, Gil; Feldman, Steven R.; Jorizzo, Joseph L.

In: Journal of the American Academy of Dermatology, Vol. 54, No. 2, 01.02.2006, p. 217-220.

Research output: Contribution to journalArticle

Hundley, Jennifer L. ; Carroll, Christie L. ; Lang, Wei ; Snively, Beverly ; Yosipovitch, Gil ; Feldman, Steven R. ; Jorizzo, Joseph L. / Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. In: Journal of the American Academy of Dermatology. 2006 ; Vol. 54, No. 2. pp. 217-220.
@article{288a56b5b8eb411c98f6e505e9939568,
title = "Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life",
abstract = "Background: Dermatomyositis affects visible skin and causes disease symptoms that can affect patients' quality of life (QOL). Methods: In all, 71 patients with dermatomyositis or dermatomyositis sine myositis completed two QOL measures (the Skindex-16 and the Dermatology Life Quality Index) and a visual analog scale for pruritus. Disease severity was assessed by Physician's Global Assessment. Results: The mean Dermatology Life Quality Index score was 10.7 and the mean Skindex-16 score was 51.1. Itching contributed to impact on both the Dermatology Life Quality Index and Skindex-16. Females reported worse QOL. Limitations: The effect of treatment on quality of life was not assessed in these analyses. Conclusion: QOL impairment in dermatomyositis is greater than in other skin conditions including psoriasis and atopic dermatitis. Pruritus is an important treatable factor that significantly impacts QOL for patients with dermatomyositis.",
author = "Hundley, {Jennifer L.} and Carroll, {Christie L.} and Wei Lang and Beverly Snively and Gil Yosipovitch and Feldman, {Steven R.} and Jorizzo, {Joseph L.}",
year = "2006",
month = "2",
day = "1",
doi = "10.1016/j.jaad.2004.12.015",
language = "English (US)",
volume = "54",
pages = "217--220",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life

AU - Hundley, Jennifer L.

AU - Carroll, Christie L.

AU - Lang, Wei

AU - Snively, Beverly

AU - Yosipovitch, Gil

AU - Feldman, Steven R.

AU - Jorizzo, Joseph L.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Background: Dermatomyositis affects visible skin and causes disease symptoms that can affect patients' quality of life (QOL). Methods: In all, 71 patients with dermatomyositis or dermatomyositis sine myositis completed two QOL measures (the Skindex-16 and the Dermatology Life Quality Index) and a visual analog scale for pruritus. Disease severity was assessed by Physician's Global Assessment. Results: The mean Dermatology Life Quality Index score was 10.7 and the mean Skindex-16 score was 51.1. Itching contributed to impact on both the Dermatology Life Quality Index and Skindex-16. Females reported worse QOL. Limitations: The effect of treatment on quality of life was not assessed in these analyses. Conclusion: QOL impairment in dermatomyositis is greater than in other skin conditions including psoriasis and atopic dermatitis. Pruritus is an important treatable factor that significantly impacts QOL for patients with dermatomyositis.

AB - Background: Dermatomyositis affects visible skin and causes disease symptoms that can affect patients' quality of life (QOL). Methods: In all, 71 patients with dermatomyositis or dermatomyositis sine myositis completed two QOL measures (the Skindex-16 and the Dermatology Life Quality Index) and a visual analog scale for pruritus. Disease severity was assessed by Physician's Global Assessment. Results: The mean Dermatology Life Quality Index score was 10.7 and the mean Skindex-16 score was 51.1. Itching contributed to impact on both the Dermatology Life Quality Index and Skindex-16. Females reported worse QOL. Limitations: The effect of treatment on quality of life was not assessed in these analyses. Conclusion: QOL impairment in dermatomyositis is greater than in other skin conditions including psoriasis and atopic dermatitis. Pruritus is an important treatable factor that significantly impacts QOL for patients with dermatomyositis.

UR - http://www.scopus.com/inward/record.url?scp=31344456716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344456716&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2004.12.015

DO - 10.1016/j.jaad.2004.12.015

M3 - Article

C2 - 16443050

AN - SCOPUS:31344456716

VL - 54

SP - 217

EP - 220

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2

ER -